GO
Loading...

Pharma companies navigating 'patent cliffs'

Monday, 29 Jul 2013 | 8:15 AM ET

Barbara Ryan, FTI Consulting, provides a preview of Pfizer and Merck's earnings, and discusses how both pharma giants have improved shareholder value through M&A.